Cooled RFA Relieves Pain Following Knee Replacement
By HospiMedica International staff writers Posted on 06 Dec 2021 |

Image: The cooled radiofrequency ablation (C-RFA) procedure (Photo courtesy of Dr. Felix Gonzalez/ RSNA)
A new study suggests cooled radiofrequency ablation (C-RFA) offers long-term relief for chronic and debilitating pain after knee replacement surgery.
Researchers at Emory University (Atlanta, GA, USA) conducted a study involving 21 patients who experienced persistent and chronic pain following total knee replacement, without any underlying hardware complications; all of the patients had failed conservative care. For the study, the patients filled out clinically validated questionnaires to assess pain severity, stiffness, functional activities of daily living, and use of pain medication before and after the C-RFA procedure.
Follow-up outcome scores were collected up to one year after the procedure. The questionnaire results showed that the patients experienced, on average, a statistically significant improvement in quality of life, with both pain and stiffness scores improving dramatically. No major complications were seen, and no patients required repeat treatment, surgical revision, or other interventions. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November-December 2021 in Chicago (IL, USA).
“The procedure's long-term relief gives it a major advantage over cortisone injections, which offer on average only about three months of pain relief. It's very encouraging that up to a year out these patients have such significant pain relief and a better quality of life,” said lead author Felix Gonzalez, MD. “With a larger propagating heat wave, you can account for the differences in nerve anatomy from patient to patient because of a larger treatment zone; treating a larger zone increases the effectiveness of the procedure.”
The C-RFA procedure involves insertion of an introducer needle under local anesthesia that targets specific nerve locations around the knee. A probe is then guided through the introducers. The tip of the probe imparts low voltage RFA to the deep sensory nerves around the knee. Water circulating through the system allows for a greater dissipation of heat from the tip of the probe.
Related Links:
Emory University
Researchers at Emory University (Atlanta, GA, USA) conducted a study involving 21 patients who experienced persistent and chronic pain following total knee replacement, without any underlying hardware complications; all of the patients had failed conservative care. For the study, the patients filled out clinically validated questionnaires to assess pain severity, stiffness, functional activities of daily living, and use of pain medication before and after the C-RFA procedure.
Follow-up outcome scores were collected up to one year after the procedure. The questionnaire results showed that the patients experienced, on average, a statistically significant improvement in quality of life, with both pain and stiffness scores improving dramatically. No major complications were seen, and no patients required repeat treatment, surgical revision, or other interventions. The study was presented at the annual meeting of the Radiological Society of North America (RSNA), held during November-December 2021 in Chicago (IL, USA).
“The procedure's long-term relief gives it a major advantage over cortisone injections, which offer on average only about three months of pain relief. It's very encouraging that up to a year out these patients have such significant pain relief and a better quality of life,” said lead author Felix Gonzalez, MD. “With a larger propagating heat wave, you can account for the differences in nerve anatomy from patient to patient because of a larger treatment zone; treating a larger zone increases the effectiveness of the procedure.”
The C-RFA procedure involves insertion of an introducer needle under local anesthesia that targets specific nerve locations around the knee. A probe is then guided through the introducers. The tip of the probe imparts low voltage RFA to the deep sensory nerves around the knee. Water circulating through the system allows for a greater dissipation of heat from the tip of the probe.
Related Links:
Emory University
Latest Critical Care News
- Wireless Implant Delivers Chemotherapy Deep into Tumors Without Side Effects
- Skin-Like Sensor Monitors Vital Signs and Tracks Healing After Surgery
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more